Content
Summary
The miniaturized checkerboard assay is a protocol designed to measure pairwise antibiotic interactions by combining drugs in a two-dimensional matrix of varying concentrations to identify synergistic or antagonistic effects. This method reduces resource consumption and experimental variation by utilizing only two 96-well plates and standard laboratory equipment over a five-day period. The process involves preparing bacterial cultures, performing serial dilution dose-response assays, and conducting linear dilution assays to normalize growth and calculate interaction metrics.
Intuition
To understand drug interactions, we must compare the combined effect of two antibiotics against the expected additive effect of each drug alone. The checkerboard assay achieves this by creating a grid where the concentration of Drug A increases along one axis and Drug B along the other. By exposing bacteria to these combinations, we can observe if the growth is lower than expected (synergy) or higher (antagonism). The miniaturized version streamlines this by using two 96-well plates instead of larger matrices, allowing for the testing of three antibiotics in duplicate while controlling for variables like solvent effects (DMSO) and bacterial density. Normalizing growth against a no-drug control isolates the specific interaction effects, ensuring that the results reflect the drug combination rather than general growth conditions.
Derivation
- Prepare bacterial cultures (E. coli) in LB Broth overnight at 37°C.
- Perform serial dilution dose-response assays by creating ten wells with decreasing drug concentrations.
- Add 20 μl of bacterial culture to each well and incubate for 12 hours.
- Measure OD600 absorbance of the plate after incubation.
- Normalize growth by dividing the growth in each well by the growth in the no-drug control.
- Define a reference dose (1x) as twice the minimum concentration resulting in no growth.
- Prepare linear dilution dose-response assays using ten concentrations based on the 1x reference.
- Calculate interaction indices using the final drug concentrations and normalized growth data.
Worked example
A researcher performs a miniaturized checkerboard assay with two antibiotics. After 12 hours of incubation, the OD600 of the no-drug control is 0.8. A well containing a specific combination of Drug A and Drug B has an OD600 of 0.1. If the expected additive growth for this combination was 0.4, what is the interaction type?
- Identify the observed growth: OD600 = 0.1.
- Identify the expected additive growth: 0.4.
- Compare observed to expected: 0.1 is significantly lower than 0.4.
- Lower growth than expected indicates a synergistic interaction.
- Note that normalization would involve dividing 0.1 by 0.8, but the comparison to the expected additive effect is the key determinant.
Answer The interaction is synergistic because the observed growth (0.1) is lower than the expected additive effect (0.4).
Common mistakes
- Ignoring experimental variation in single-drug effects, which can make preparation difficult.
- Using traditional 8x8 matrices which are resource-intensive and time-consuming compared to the miniaturized version.
- Failing to control solvent effects by including solvent-only controls and matching solvent concentrations in drug dilutions.